Online Only Articles

Genomic and outcome analysis of adult T-cell lymphoblastic lymphoma

Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China;Lymphoma Diagnosis and Treatment Center of Henan Province, Zhengzhou, China
Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China;Lymphoma Diagnosis and Treatment Center of Henan Province, Zhengzhou, China
Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China;Institute of Clinical Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China;Institute of Clinical Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China;Institute of Clinical Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China;Institute of Clinical Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China;Institute of Clinical Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China;Institute of Clinical Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China;Institute of Clinical Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China;Lymphoma Diagnosis and Treatment Center of Henan Province, Zhengzhou, China
Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China;Lymphoma Diagnosis and Treatment Center of Henan Province, Zhengzhou, China
Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China;Lymphoma Diagnosis and Treatment Center of Henan Province, Zhengzhou, China
Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China;Lymphoma Diagnosis and Treatment Center of Henan Province, Zhengzhou, China
Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China;Lymphoma Diagnosis and Treatment Center of Henan Province, Zhengzhou, China
Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China;Lymphoma Diagnosis and Treatment Center of Henan Province, Zhengzhou, China
Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China;Lymphoma Diagnosis and Treatment Center of Henan Province, Zhengzhou, China
Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China;Lymphoma Diagnosis and Treatment Center of Henan Province, Zhengzhou, China
Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China;Lymphoma Diagnosis and Treatment Center of Henan Province, Zhengzhou, China
Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China;Lymphoma Diagnosis and Treatment Center of Henan Province, Zhengzhou, China
Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China;Lymphoma Diagnosis and Treatment Center of Henan Province, Zhengzhou, China
Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China;Lymphoma Diagnosis and Treatment Center of Henan Province, Zhengzhou, China
Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China;Lymphoma Diagnosis and Treatment Center of Henan Province, Zhengzhou, China
Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China;Lymphoma Diagnosis and Treatment Center of Henan Province, Zhengzhou, China
Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
Novogene Bioinformatics Technology Co., Ltd., Xueqing Road, Beijing, China
The Academy of Medical Science of Zhengzhou University, Zhengzhou, China
Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China;Lymphoma Diagnosis and Treatment Center of Henan Province, Zhengzhou, China
Vol. 105 No. 3 (2020): March, 2020 https://doi.org/10.3324/haematol.2019.220863